1207069-46-2

Upstream product

• 1207069-50-8 C₂₄H₄₃NO₄Si 
• 994-30-9 triethylsilyl chloride 
• 90865-70-6 [3R]-4-Benzyloxy-3-methylbutanal 
• 1112-56-7 tetravinyltin (IV) 

Downstream Products

• 1207069-44-0 C₅₅H₉₀O₆Si₃ 
• 1207069-43-9 C₅₅H₉₀O₆Si₃ 
• 1207069-51-9 C₄₉H₇₆O₅Si₂ 
• 1207069-55-3 C₄₂H₇₀O₅Si₂ 
• 1207069-41-7 C₄₂H₆₈O₅Si₂ 
• 1207069-56-4 C₅₆H₈₅IO₆Si₂ 
• 1207069-57-5 C₄₀H₆₇IO₆Si 
• 1207069-58-6 C₄₁H₆₇IO₇Si 
• 1279693-56-9 C₄₃H₇₀O₄Si₂ 

Relevant academic research and scientific papers

MACROLIDE COMPOUND HAVING ANTICANCER EFFECT

The present invention relates to a macrolide compound expected to have a cell growth-inhibiting activity and a novel anticancer drug utilizing the compound. Specifically, the invention relates to a compound represented by Formula (I) or (II) or a pharmaceutically acceptable salt thereof and relates to a cell growth inhibitor and an anticancer drug each containing the compound or the salt as an active ingredient.

Total synthesis and biological assessment of (-)-Exiguolide and analogues

We describe herein an enantioselective total synthesis of (-)-exiguolide, the natural enantiomer. The methylene bis(tetrahydropyran) substructure was efficiently synthesized by exploiting olefin cross-metathesis for the assembly of readily available acycl

Total synthesis of (-)-exiguolide

[Chemical equation presented] Total synthesis of (-)-exiguolide, the natural enantiomer, has been accomplished for the first time. The bis(tetrahydropyran) subunit was efficiently synthesized via consecutive olefin cross-metathesis/intramolecular oxa-conj